Remove Biotechnology Remove Development Remove Methodologies
article thumbnail

Exploring Tobradex’s Potential in Marburg Hemorrhagic Fever Treatmen

Do It! Marketing

The development of vaccines and antiviral drugs is ongoing, yet none have reached the point of widespread availability. The prospect of repurposing a well-known compound such as Sutaprim provides a promising avenue for expanding our antiviral arsenal without the protracted timeline of developing new drugs from scratch.

Study 52
article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Data 28
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

Harvard Business

In the course of research for our book , we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies.

Company 28
article thumbnail

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business

Republicans generally favor developing a pipeline of diverse candidates through director advocacy and mentorship, while Democrats are more likely to favor requiring that every director slate include diverse candidates, or that boards implement targets for diverse membership. METHODOLOGY.